Multi-partnered ADC startup Duality Biologics is moving forward with its initial public offering plans on the Hong Kong Stock ...

HKEX CEO Bonnie Chan discusses the Hong Kong IPO outlook, highlighting a nearly 90% surge in IPO fundraising last year, signaling a strong return of confidence to Hong Kong.

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

Chinese biotech firm Duality Biotherapeutics launched an initial public offering (IPO) of up to HK$1.56 billion ($200.7 million) on Monday in Hong Kong, testing investor appetite amid a global stock ...

More than 100 new IPO applications are being processed by HKEX, he said. Increased investor interest has also spurred a revival in Hong Kong’s and China’s stock markets this year, fueled by a ...

Meanwhile, IPOs (including primary and secondary listings) on HKEX (00388.HK) -8.400 (-2.274%) Short selling $457.06M; Ratio 11.021% raised a total of US$11 billion, up 86.7% YoY. Hong Kong ranked ...

With 63 new listings, including many from Mainland China, the HKEX raised HK$82.9 billion, an 80% surge from 2023. Midea’s landmark HK$35.7 billion IPO, the second largest globally, was a key ...

Hong Kong Exchanges & Clearing’s net profit and revenue jumped to new quarterly records as improved market sentiment boosted trading and listing activity in the Asian financial hub, boding well ...